Clinical trials of COVID-19 drug begin in New York - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Clinical trials of COVID-19 medicine begin in New York

For the treatment of coronavirus in New York will begin to issue an antimalarial drug. If the tests are successful, it will be issued to many New Yorkers. This is reported by the publication "News".

Photo: Shutterstock

About the preparation

March 24 in New York will begin to issue a drug for the treatment of patients with coronavirus. The drug is called Plaquenil (Hydroxychloroquine). This was stated by US President Donald Trump. “I am pleased to report that clinical trials of existing drugs that can be effective against the virus will begin in New York,” he said.

It is reported that this drug has previously proven itself in the fight against malaria.

If the tests are successful, it will be issued to many New Yorkers.

Trump also noted that, on his instructions, the federal government will help acquire a large amount of Hydroxychloroquine if necessary.

The reaction of authorities and specialists

New York Governor Andrew Cuomo confirmed that the state will begin clinical trials of a malaria drug that the president proposed to use to treat those infected with coronavirus. “The President is optimistic about these drugs, and we are all confident that they can work,” Cuomo said at his daily news conference in Albany, the newspaper writes. The National Interest.

Cuomo said health officials had purchased 750 doses of the malaria drug chloroquine, 70 doses of its derivative hydroxychloroquine, and 10 doses of the antibiotic Zithromax for use in the trial.

At the same time, some health officials expressed “cautious optimism” regarding the drug. Dr. Peter Hotez, Dean of the Baylor School of Medicine, told the Daily Caller News Foundation that chloroquine and hydroxychloroquine have “great potential,” but “we don’t have much data yet.”

As previously сообщалось, the Federal Food and Drug Administration (FDA) is investigating the effects of hydroxychloroquine as a potential treatment for COVID-19, but has not yet made any recommendations.

On the subject: If you become infected with a coronavirus: 10 steps to take

In addition, on March 21, the infectious disease specialist Dr. Edsel Salvana warned patients not to take hydroxychloroquine and azithromycin unless prescribed by a doctor. “Both drugs affect the QT interval of your heart and can lead to arrhythmias and sudden death, especially if you take other drugs or have heart disease,” he wrote.

At the same time, Dr. Mehmet Oz said he was optimistic about French research data. “These drugs were extremely effective in reducing the viral load in people with COVID-19,” Oz explained in an interview with Fox and Friends. “We could make this virus look like a flu virus, if that's true.”

Read more on ForumDaily New York.

Other interesting materials on ForumDaily New York:

Miscellanea treatment New York coronavirus
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1066 requests in 1,175 seconds.